Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Technology in Cancer Research & Treatment|March 11, 2003
Identification of tumor-associated antigens using proteomicsFrançois L Naour, Franck Brichory, Laura Beretta, et al.Molecular & Cellular Proteomics : MCP|July 4, 2002
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysisFrançois Le Naour, Franck Brichory, David E Misek, et al.Journal of Proteome Research|May 31, 2008
Scaled-down purification protocol to access proteomic analysis of 20S proteasome from human tissue samples: comparison of normal and tumor colorectal cellsManuelle Ducoux-Petit, Sandrine Uttenweiler-Joseph, Franck Brichory, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
Preclinical Characterization of DPI-4452: A 68Ga/177Lu Theranostic Ligand for Carbonic Anhydrase IXFrédéric Massière, Norbert Wiedemann, Inês Borrego, et al.The Journal of Biological Chemistry|December 21, 2002
Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone functionBong Kyung Shin, Hong Wang, Anne Marie Yim, et al.Therapeutic Advances in Medical Oncology|May 12, 2025
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib studyGlenwood Goss, Tudor Ciuleanu, Rodryg Ramlau, et al.Clinical and Translational Science|March 20, 2021
Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancerCarlos Gomez-Roca, Caroline Even, Christophe Le Tourneau, et al.Cancer Discovery|April 30, 2021
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in CholangiocarcinomaJames M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.Pageof 1